Allergan CEO Saunders to oversee 'Pfizergan' commercial ops; Novartis picks up 2 Cosentyx nods in Europe;

> Allergan ($AGN) CEO Brent Saunders will be responsible for the oversight of all Pfizer ($PFE) and Allergan's combined commercial businesses under the new deal agreement between the two. Release

> Novartis ($NVS) has won European approval for Cosentyx in ankylosing spondylitis and psoriatic arthritis. Report

> AstraZeneca ($AZN) has agreed to sell U.S. rights to Crohn's disease drug Entocort to Perrigo ($PRGO) for $380 million. Release

> Gilead ($GILD) has won a European green light for HIV regimen Genvoya. Release

> Merck ($MRK) has launched antibiotic Zerbaxa in the U.K. More

And Finally... AstraZeneca ($AZN) will sponsor a new health and science education element of U.K. soccer team Cambridge United's school sports program. More

Suggested Articles

Novartis is taking its MBC campaign to Instagram with a newly launched video series as part of the five-year “Make Your Dialogue Count” effort.

FDA researchers uncover more concerns and fears among front-line workers and minority groups about a COVID-19 vaccine.

Provention Bio wants to connect the familial threads around Type 1 diabetes with two new campaigns—one targeted at doctors and the other at consumers.